Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

ARTVATNM

Artiva Biotherapeutics, Inc.

ARTV · $4.23

35Weak

Actinium Pharmaceuticals, Inc.

ATNM · $1.53

80Strong

Area by area

Overall Quant Score

How does it look overall? (out of 100)

ARTV

35/100

ATNM

80/100

Quality

Is it a profitable, well-run business?

ARTV

2.0/10

ATNM

9.5/10

Growth

Is the company growing?

ARTV

0.0/10

ATNM

5.9/10

Valuation

Is the price reasonable? (higher = cheaper)

ARTV

3.3/10

ATNM

8.8/10

Risk

How risky are the shares? (higher = lower risk)

ARTV

0.4/10

ATNM

5.0/10

Momentum

Is the share price trending up?

ARTV

3.1/10

ATNM

9.5/10

Financial strength

Is the balance sheet healthy?

ARTV

6.8/10

ATNM

5.8/10

The balanced view

Model-generated

Artiva Biotherapeutics, Inc.

This company scores below average, with a healthy balance sheet, although its growth has been slow.

Leads on: financial strength

Best feature: healthy balance sheet (Debt / Equity: 0.03)

Watch out: growth is slow or negative (Revenue growth (FY): -100.0%)

Actinium Pharmaceuticals, Inc.

This company scores well across most areas, with supportive analyst views and a positive price trend.

Leads on: quality, growth, valuation, risk, momentum

Best feature: analysts broadly positive (Analyst buy share: 100%)

Watch out: weakest area: risk profile (Price volatility (1Y, annualised): 71%)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.